Next |
home / stock / gemp / gemp message board
Subject | By | Source | When |
---|---|---|---|
Why does this keep dropping with merger news? | Cowman45 | investorshub | 12/06/2019 2:38:13 PM |
Ok the 8k on the 9th, item 3.01, | Cowman45 | investorshub | 08/15/2019 6:24:59 PM |
A lot of form 4s yesterday for acquiring shares..... | Cowman45 | investorshub | 07/27/2019 9:29:19 PM |
* * $GEMP Video Chart 07-25-2019 * * | ClayTrader | investorshub | 07/25/2019 8:34:24 PM |
In 1.09 lets go | stock1ace1 | investorshub | 07/25/2019 1:30:58 PM |
Everything You Need For Your Premarket Including Gemplus/NeuroBo | behindthebid | investorshub | 07/25/2019 1:17:37 PM |
Yes, theyve been relentless. | tavito | investorshub | 06/26/2019 2:32:43 PM |
So dilution likely. | willlbone | investorshub | 06/26/2019 2:04:17 PM |
* * $GEMP Video Chart 09-13-18 * * | ClayTrader | investorshub | 09/13/2018 9:19:15 PM |
Going to be hard. If it does, | PAC | investorshub | 09/11/2018 12:53:39 PM |
going to pass 3.27? | otchype | investorshub | 09/11/2018 12:51:51 PM |
going to pass 3.27? | otchype | investorshub | 09/11/2018 12:50:21 PM |
There not saying it anymore since phase 2 | jdlamont | investorshub | 09/09/2018 11:15:20 PM |
They didn't say when, this year is far | otchype | investorshub | 09/09/2018 9:19:44 PM |
Raymond James idiots had price target raised to | gamesetmatch101 | investorshub | 09/07/2018 4:59:44 PM |
YES, and some | PAC | investorshub | 09/07/2018 2:36:19 PM |
will we fill the gap? | Franky-vincent | investorshub | 09/07/2018 1:52:00 PM |
There it is. | VERITAS77 | investorshub | 09/07/2018 2:34:35 AM |
* * $GEMP Video Chart 09-06-18 * * | ClayTrader | investorshub | 09/06/2018 9:31:17 PM |
Finally we see that breakout. Nice day | incredible199 | investorshub | 09/06/2018 9:24:51 PM |
News, Short Squeeze, Breakout and More Instantly...
Gemphire Therapeutics Inc. Company Name:
GEMP Stock Symbol:
NASDAQ Market:
Gemphire Therapeutics Inc. Website:
ANN ARBOR, Mich., Dec. 30, 2019 (GLOBE NEWSWIRE) -- The pending merger between Gemphire Therapeutics Inc. (NASDAQ:GEMP) and NeuroBo Pharmaceuticals, Inc. is currently expected to close after market hours today, Monday, December 30, 2019, subject to satisfaction or waiver of all closing cond...
ANN ARBOR, Mich., Dec. 06, 2019 (GLOBE NEWSWIRE) -- Gemphire Therapeutics Inc. (NASDAQ:GEMP) announced today that, based upon the final vote count certified by the independent inspector of elections for the annual meeting of stockholders held December 6, 2019, its stockholders approved all ...
LIVONIA, Mich., Aug. 09, 2019 (GLOBE NEWSWIRE) -- Gemphire Therapeutics Inc. (NASDAQ:GEMP), a clinical-stage biopharmaceutical company developing and commercializing therapies for the treatment of dyslipidemia, a serious medical condition that increases the risk of life-threatening cardiova...